Back to News
Market Impact: 0.2
BTIG Upgrades NeoGenomics to Buy from Neutral
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
BTIG upgraded NeoGenomics from Neutral to Buy on October 6, 2026. Fintel reported three total analyst actions that day, but the article excerpt does not specify the other actions or provide market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
NEO0.50
More News
- Anthropic will be 'most ridiculous IPO' of year, analyst says
- Streamex CIO Mitchell Williams sells $35,239 in company stock
- New data strengthens our faith in a TJX comeback. Plus, the Nvidia-Microsoft PC is here
- Another Micron triple? Where we agree with this wildly bullish call and where we don't
- Farm equipment stocks after the FTC and USDA joint inquiry: AGCO, Deere and CNH compared
- Micron to nearly triple as investors wake up to value, D.A. Davidson says : 'If you don't buy it, they will'